Massachusetts, United States of America
112 employees
Founded 2011
Verified active February 2, 2026

Key Highlights

  • ABclonal Technology's advanced protein expression system and antibody production capabilities make it a leader in the biotechnology research sector.
  • The company's fourth-generation rabbit monoclonal antibody technology enhances the development of in vitro diagnostic products and customized IVD materials.
  • ABclonal's collaboration with scientists from world-class universities drives innovation and quality in life science research.
  • The company's commitment to improving research quality and its robust technological infrastructure set it apart in the competitive landscape.
  • ABclonal Technology's focus on early research and raw material development services supports the advancement of biotechnology and life sciences.

About ABclonal Technology

ABclonal Technology is a Massachusetts-based company specializing in biology research reagents and services. Founded in 2011, ABclonal employs 112 professionals dedicated to enhancing life science research through high-quality antibodies, proteins, ELISA kits, NGS Prep Kits, and molecular enzymes. The company leverages advanced technology, including a comprehensive prokaryotic and eukaryotic protein expression system, and a fourth-generation rabbit monoclonal antibody technology. ABclonal also develops in vitro diagnostic products and customized IVD materials for early research and raw material development services.

ABclonal Technology's mission is to improve the quality of life science research by providing reliable and innovative research tools. The company's advanced systems and technologies enable the development of diagnostic products and customized materials, supporting the early stages of research and development. ABclonal's commitment to quality and innovation positions it as a key player in the biotechnology and life sciences sectors.

With a focus on research and development, ABclonal Technology collaborates with scientists from world-class universities to drive advancements in the field. The company's comprehensive protein expression system and antibody production capabilities make it a valuable partner for researchers and developers in the biotechnology industry. ABclonal's dedication to improving research quality and its robust technological infrastructure set it apart in the competitive landscape of life science research.

Technology Stack

  • ChIP
  • ChIP-seq
  • WB
  • IHC
  • ELISA
  • NGS

Connect with ABclonal Technology

Why Contact ABclonal Technology?

B2B professionals should contact ABclonal Technology for high-quality research reagents and services that enhance life science research. The company's advanced technologies and commitment to innovation make it an ideal partner for research and development in the biotechnology and life sciences sectors.

Who Should Contact ABclonal Technology for Business?

Sales teams selling biotechnology research reagents, recruiters seeking roles in life science research, and partners offering advanced diagnostic products and IVD materials should reach out to ABclonal Technology.

Categories

  • Antibodies
  • Proteins
  • ELISA Kits
  • NGS Prep Kits
  • Molecular Enzymes
  • Protein Expression
  • Monoclonal Antibodies
  • IVD Materials
  • Research Tools
  • Life Science Research

More Biotechnology Companies

Frequently Asked Questions

What does ABclonal Technology do?
ABclonal Technology is a biotechnology company that develops, manufactures, and sells antibodies, recombinant proteins, peptides, ELISA kits, and NGS products for research in areas such as epigenetics, cancer, and immunology.
How many employees does ABclonal Technology have?
ABclonal Technology has approximately 112 employees.
Where is ABclonal Technology headquartered?
Woburn, Massachusetts, United States of America
What industry is ABclonal Technology in?
ABclonal Technology operates in Biotechnology, Life Sciences, Research Reagents.
When was ABclonal Technology founded?
ABclonal Technology was founded in 2011.
Is ABclonal Technology still active?
Yes, ABclonal Technology was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to ABclonal Technology?
Research ABclonal Technology's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.

Ready to Sell to ABclonal Technology?

Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.

Discover Similar Companies
Find Decision Makers
Outreach Monitoring

View pricing · FAQs · Contact us

Last verified: February 2, 2026

Backed by startup programs from